DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gooderham, N. J.
Right arrow Articles by Davies, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gooderham, N. J.
Right arrow Articles by Davies, D. S.

Vol. 29, Issue 4, 529-534, April 2001

Food-Derived Heterocyclic Amine Mutagens: Variable Metabolism and Significance to Humans

Nigel J. Gooderham, Stephen Murray, Anthony M. Lynch, Masoud Yadollahi-Farsani, Kaicun Zhao, Alan R. Boobis, and Donald S. Davies

Molecular Toxicology and Clinical Pharmacology, Imperial College School of Medicine, London, United Kingdom

The cooking of meat has been found to generate compounds that possess extreme mutagenicity when examined in short term tests. This observation led to the isolation and identification of a family of mutagenic chemicals, all of which are heterocyclic amines. These amines are potent bacterial and eukaryotic cell mutagens, and all of those tested have been found to induce tumors in laboratory animals. Metabolic activation of the heterocyclic amines predominantly involves CYP1-mediated N-hydroxylation and then O-esterification by phase II enzymes. In contrast, carbon oxidation, glucuronidation, and sulfation reactions at sites other than the hydroxylamine yield detoxication metabolites. In humans, the activities of these pathways are known to vary between individuals and are likely to influence susceptibility to the genetic toxicity of the heterocyclic amines. Clearly, accurate determination of human exposure to the heterocyclic amines and identification of the key enzyme systems involved and their regulation will be required for rational assessment of the risk and will help devise strategies to reduce such risk.


Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
CarcinogenesisHome page
A. Agudo, M. Peluso, N. Sala, G. Capella, A. Munnia, S. Piro, F. Marin, R. Ibanez, P. Amiano, M.J. Tormo, et al.
Aromatic DNA adducts and polymorphisms in metabolic genes in healthy adults: findings from the EPIC-Spain cohort
Carcinogenesis, June 1, 2009; 30(6): 968 - 976.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E. D. Louis, W. Zheng, L. Applegate, L. Shi, and P. Factor-Litvak
Blood harmane concentrations and dietary protein consumption in essential tremor
Neurology, August 9, 2005; 65(3): 391 - 396.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. Sachse, G. Smith, M. J.V. Wilkie, J. H. Barrett, R. Waxman, F. Sullivan, D. Forman, D. T. Bishop, and C.R. Wolf
A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer
Carcinogenesis, November 1, 2002; 23(11): 1839 - 1850.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.